B
Catalyst Pharmaceuticals, Inc. CPRX
$21.02 $0.150.72%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 141.82M 128.70M 122.71M 98.51M 110.57M
Total Other Revenue -- -- -- -- --
Total Revenue 141.82M 128.70M 122.71M 98.51M 110.57M
Cost of Revenue 14.57M 22.56M 18.39M 15.10M -73.89M
Gross Profit 127.25M 106.13M 104.32M 83.41M 184.46M
SG&A Expenses 44.19M 45.88M 40.73M 46.94M 42.04M
Depreciation & Amortization 9.34M 9.35M 9.34M 9.34M 9.06M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 78.98M 77.79M 68.46M 71.38M 68.88M
Operating Income 62.84M 50.91M 54.25M 27.13M 41.69M
Income Before Tax 74.18M 57.21M 55.79M 29.09M 46.71M
Income Tax Expenses 18.25M 13.32M 14.99M 5.81M 11.86M
Earnings from Continuing Operations 55.94M 43.88M 40.79M 23.28M 34.84M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 55.94M 43.88M 40.79M 23.28M 34.84M
EBIT 62.84M 50.91M 54.25M 27.13M 41.69M
EBITDA 72.30M 60.36M 63.68M 36.56M 50.84M
EPS Basic 0.47 0.37 0.35 0.20 0.33
Normalized Basic EPS 0.35 0.29 0.31 0.16 0.25
EPS Diluted 0.44 0.35 0.33 0.19 0.31
Normalized Diluted EPS 0.33 0.28 0.29 0.15 0.24
Average Basic Shares Outstanding 119.89M 118.93M 118.18M 116.81M 106.71M
Average Diluted Shares Outstanding 126.28M 125.41M 124.66M 123.40M 113.76M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings